Amazon’s Unit Whole Foods Sued Over Beef Marketing Slogan Claiming ‘No Antibiotics’
Amazon Inc's (NASDAQ: AMZN) Whole Foods Market unit is being accused in a lawsuit of falsely marketing beef with the slogan "No Antibiotics, Ever."
This High Yielding Stock Shares A Sector With FAANG Stocks Like Netflix, But Outperforms In This Characteristic
As the communication services sector has been lagging behind the S&P 500 since October 2021, it makes for an interesting case to find undervalued stocks that have been beaten up by the volatile market in this sector. Here is one dividend stock in the communications sector that is down 1.91% over the past twelve months.
Ansys And AMD Collaborate To Speed Simulation Of Large Structural Mechanical Models Up To 6x Faster
Ansys delivers one of the first commercial finite element analysis solvers supporting AMD Instinct™ accelerators
Ansys is investing in graphics processing units (GPUs) as an emerging, sustainable and powerful
Integra LifeSciences Recalls CereLink Intracranial Pressure Monitors, Revises Guidance
Integra LifeSciences Holdings Corporation (NASDAQ:IART) initiated an immediate voluntary removal of all CereLink intracranial pressure monitors after customer reports about monitors…
Moderna Plans US Application Submission For COVID-19 Omicron Adapted Booster ‘Very Soon’
Moderna Inc (NASDAQ:MRNA) plans to file data with the FDA very soon, seeking approval for a booster shot targeting…
2 Dividend Stocks The Activist Investor Behind Disney Has Also Been Buying
Activist investor Dan Loeb is the Chief Executive Officer and founder of hedge fund Third Point Management, which has recently opened a stake in The Walt Disney Company (NYSE: DIS) of 1,000,000 shares.
Amgen Announces Top-line Results From Phase 3 Study Of ABP 959, Biosimilar Candidate To Soliris
Study Evaluated the Efficacy, Safety and Immunogenicity of ABP 959 Compared to Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria
THOUSAND OAKS, Calif., Aug. 23, 2022 /PRNewswire/ -- Amgen
Health Canada Approves OPDIVO With Chemotherapy For Adult Patients With Resectable Non-Small Cell Lung Cancer
First and-only immunotherapy-based treatment for use before surgery for non-small cell lung cancer in Canada
Significant improvement in event-free survival and pathological complete
Medtronic Q1 Earnings Within Expectation, Sees Higher Currency Headwind On FY23 Sales
Medtronic Plc’s (NYSE:MDT) Q1 FY23 sales of $7.37 billion decreased 8% Y/Y on a reported basis and 4% organically, beating the…
Alcon Buys Aerie Pharma For $770M To Enhance Its Ophthalmic Pharma Portfolio
Alcon AG (NYSE:ALC) has agreed to acquire Aerie Pharmaceuticals Inc (NASDAQ:AERI) for $15.25 per share, valuing Aerie at about $770 million. The…